2015
DOI: 10.1016/j.meddos.2014.11.005
|View full text |Cite
|
Sign up to set email alerts
|

Dosimetric experience with 2 commercially available multilumen balloon-based brachytherapy to deliver accelerated partial-breast irradiation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2018
2018
2020
2020

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 36 publications
(39 reference statements)
0
1
0
Order By: Relevance
“…Hence, the skin maximum point dose was limited to ≤ 145% of the prescribed dose in the use of a single-lumen MammoSite® balloon applicator (Hologic Inc., Bedford, MA, USA) [10]. Later, with multi-lumen balloon (MLB) applicators such as MammoSite® MLB (Hologic Inc.) and Contura® (Hologic Inc.), the skin maximum point dose was restricted to ≤ 125% of the prescribed dose [11,12]. Furthermore, the strut-adjusted volume implant applicator, SAVI® (Cianna Medical, Aliso Viejo, CA, USA), which is a single entry interstitial applicator (nonballoon), was able to reduce the maximum skin dose constraint to 100% of the prescribed dose [13].…”
Section: Introductionmentioning
confidence: 99%
“…Hence, the skin maximum point dose was limited to ≤ 145% of the prescribed dose in the use of a single-lumen MammoSite® balloon applicator (Hologic Inc., Bedford, MA, USA) [10]. Later, with multi-lumen balloon (MLB) applicators such as MammoSite® MLB (Hologic Inc.) and Contura® (Hologic Inc.), the skin maximum point dose was restricted to ≤ 125% of the prescribed dose [11,12]. Furthermore, the strut-adjusted volume implant applicator, SAVI® (Cianna Medical, Aliso Viejo, CA, USA), which is a single entry interstitial applicator (nonballoon), was able to reduce the maximum skin dose constraint to 100% of the prescribed dose [13].…”
Section: Introductionmentioning
confidence: 99%